+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Viral Vector Manufacturing Market by Vector Type (Adenoviral Vectors, Baculoviral Vectors, Herpes Simplex Vectors), Workflow (Downstream Processing, Upstream Processing), Delivery Method, Technology, Disease Indication, Application, End User - Global Forecast 2025-2030- Product Image
Viral Vector Manufacturing Market by Vector Type (Adenoviral Vectors, Baculoviral Vectors, Herpes Simplex Vectors), Workflow (Downstream Processing, Upstream Processing), Delivery Method, Technology, Disease Indication, Application, End User - Global Forecast 2025-2030- Product Image
Sale

Viral Vector Manufacturing Market by Vector Type (Adenoviral Vectors, Baculoviral Vectors, Herpes Simplex Vectors), Workflow (Downstream Processing, Upstream Processing), Delivery Method, Technology, Disease Indication, Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 181 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5613111
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Viral vector manufacturing is rapidly transforming biopharmaceutical development, delivering the frameworks required to meet evolving demands for advanced gene therapies, vaccines, and cell-based treatments. Senior decision-makers must navigate a dynamic environment defined by technological innovation, complex supply chains, and evolving global regulations.

Market Snapshot: Viral Vector Manufacturing Market Size and Growth

The Viral Vector Manufacturing Market grew from USD 9.19 billion in 2024 to USD 11.00 billion in 2025. It is expected to continue growing at a CAGR of 20.03%, reaching USD 27.50 billion by 2030. This strong trajectory highlights the sector’s rapid response to global therapeutic requirements, placing a premium on operational excellence and scalable infrastructure.

Scope & Segmentation

This report delivers a comprehensive analysis of the viral vector manufacturing landscape, detailing key segments, emerging technologies, and regional dynamics shaping the future of next-generation biopharmaceuticals.

  • Vector Types: Adenoviral, Baculoviral, Herpes Simplex, Lentiviral vectors, Plasmid DNA, Retrovirus
  • Workflow Processes: Downstream processing (formulation, purification), Upstream processing (bioreactors, cell culture systems, media formulations)
  • Delivery Methods: Ex vivo (cell transduction, cell re-infusion), In vivo (direct injection, intravenous route, oral administration)
  • Technologies: Purification techniques (chromatography, ultrafiltration), Transfection methods (chemical-based, electroporation)
  • Disease Indications: Cardiovascular diseases, genetic disorders, infectious diseases, metabolic disorders
  • Applications: Gene therapy (inherited and oncological disorders, single gene mutations), Oncology research (gene inactivation, oncolytic virotherapy, tumor suppressor genes), Vaccinology (cancer, infectious, zoonotic diseases)
  • End Users: Biotechnology companies (large enterprises, start-ups), Pharmaceutical companies (manufacturing, R&D), Academic and government research labs
  • Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (UK, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, and others), Asia-Pacific (China, India, Japan, Australia, South Korea, and others)
  • Key Industry Players: ABL Inc., Batavia Biosciences B.V. by CJ Cheiljedang, Biovian Oy, Charles River Laboratories International, Inc., Danaher Corporation, FUJIFILM Diosynth Biotechnologies U.S.A., Inc., GE HealthCare Technologies, Inc., Lonza Group Ltd., Novartis AG, Thermo Fisher Scientific Inc., and more

Key Takeaways: Strategic Insights for Viral Vector Manufacturing

  • Viral vector manufacturing has become a foundational technology in next-generation therapeutics, driving innovation in gene therapy, vaccine, and oncology pipelines.
  • Collaboration between academia, biotech start-ups, and global pharmaceutical companies accelerates advancements in vector design, process optimization, and quality management.
  • Single-use bioreactors, advanced purification systems, and digital process analytics are being integrated to improve yields, ensure consistency, and reduce contamination risks.
  • The adoption of platform manufacturing and agile partnerships fosters rapid transition of laboratory discoveries into clinical and commercial applications.
  • Regional manufacturing capabilities in the Americas, Europe, Middle East & Africa, and Asia-Pacific drive competitiveness, with each geography leveraging distinct regulatory and infrastructure strengths.
  • Smaller contract manufacturers are adjusting business models in response to global supply chain shifts and operational cost changes, ensuring sustained market participation.

Tariff Impact: Navigating Cost and Supply Chain Shifts

New United States tariffs in 2025 on raw materials and equipment used for viral vector production have driven up operational expenditures across the global industry. Manufacturers are actively strengthening procurement processes, exploring domestic sourcing, and building buffer inventories to offset lead time volatility. The shift has heightened attention on cost management strategies and accelerated digitalization for supply chain visibility and resilience.

Methodology & Data Sources

This report synthesizes insights from senior executive interviews, expert consultations, and a review of peer-reviewed literature, patent filings, and case studies. Cross-referencing qualitative and quantitative findings ensures reliable, actionable intelligence targeted to the realities of viral vector manufacturing.

Why This Report Matters

  • Support strategic decisions by mapping disruptive technologies, market opportunities, and regulatory priorities in viral vector manufacturing.
  • Benchmark operational models and competitive positioning against top industry players through clear segmentation and actionable research insights.
  • Enhance risk mitigation by understanding the structural impact of tariffs, supply chain strategies, and global regulatory shifts on cost and delivery timelines.

Conclusion

The viral vector manufacturing market continues to evolve through innovation, strategic partnerships, and regional momentum. Organizations that prioritize scalability, digital transformation, and cross-sector collaboration will be best positioned to deliver next-generation therapies to patients efficiently and reliably.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Scaling up adeno-associated virus production using single-use bioreactor systems for commercial demands
5.2. Integration of continuous manufacturing and inline analytics to optimize viral vector process efficiency
5.3. Adoption of high-throughput digital monitoring and AI-driven process control for vector quality consistency
5.4. Advancements in chromatography-based purification to improve viral vector potency and yield
5.5. Strategic partnerships between gene therapy developers and CDMOs to address manufacturing bottlenecks
5.6. Implementation of serum-free media formulations to reduce contamination risks in viral vector cultures
5.7. Regulatory harmonization efforts to streamline global approvals for viral vector manufacturing facilities
5.8. Decentralized point-of-care vector manufacturing models to support personalized gene therapies
5.9. Development of stable producer cell lines to minimize transient transfection variability and costs
5.10. Innovations in aseptic fill-and-finish technologies to accelerate time-to-market for viral vector products
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Viral Vector Manufacturing Market, by Vector Type
8.1. Introduction
8.2. Adenoviral Vectors
8.3. Baculoviral Vectors
8.4. Herpes Simplex Vectors
8.5. Lentiviral Vectors
8.6. Plasmid DNA
8.7. Retrovirus
9. Viral Vector Manufacturing Market, by Workflow
9.1. Introduction
9.2. Downstream Processing
9.2.1. Formulation
9.2.2. Purification
9.3. Upstream Processing
9.3.1. Bioreactors
9.3.2. Cell Culture Systems
9.3.3. Media Formulations
10. Viral Vector Manufacturing Market, by Delivery Method
10.1. Introduction
10.2. Ex Vivo
10.2.1. Cell Re-infusion
10.2.2. Cell Transduction
10.3. In Vivo
10.3.1. Direct Injection
10.3.2. Intravenous Route
10.3.3. Oral Administration
11. Viral Vector Manufacturing Market, by Technology
11.1. Introduction
11.2. Purification Techniques
11.2.1. Chromatography
11.2.2. Ultrafiltration
11.3. Transfection Methods
11.3.1. Chemical-Based
11.3.2. Electroporation
12. Viral Vector Manufacturing Market, by Disease Indication
12.1. Introduction
12.2. Cardiovascular Diseases
12.3. Genetic Disorders
12.4. Infectious Diseases
12.5. Metabolic Disorders
13. Viral Vector Manufacturing Market, by Application
13.1. Introduction
13.2. Gene Therapy
13.2.1. Inherited Disorders
13.2.2. Oncological Disorders
13.2.3. Single Gene Mutations
13.3. Oncology Research
13.3.1. Gene Inactivation
13.3.2. Oncolytic Virotherapy
13.3.3. Tumor Suppressor Genes
13.4. Vaccinology
13.4.1. Cancer Vaccines
13.4.2. Infectious Diseases
13.4.3. Zoonotic Diseases
14. Viral Vector Manufacturing Market, by End User
14.1. Introduction
14.2. Biotechnology Companies
14.2.1. Large Enterprises
14.2.2. Start-Ups
14.3. Pharmaceutical Companies
14.3.1. Manufacturing
14.3.2. Research and Development
14.4. Research Institutions
14.4.1. Academic Laboratories
14.4.2. Government Labs
15. Americas Viral Vector Manufacturing Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Viral Vector Manufacturing Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Viral Vector Manufacturing Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. ABL Inc.
18.3.2. Batavia Biosciences B.V. by CJ Cheiljedang
18.3.3. Biovian Oy
18.3.4. Charles River Laboratories International, Inc.
18.3.5. Creative Biogene
18.3.6. Danaher Corporation
18.3.7. FinVector Oy
18.3.8. FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
18.3.9. GE HealthCare Technologies, Inc.
18.3.10. Genezen Laboratories, Inc.
18.3.11. Kaneka Eurogentec S.A.
18.3.12. Lonza Group Ltd.
18.3.13. MaxCyte, Inc.
18.3.14. Merck KGaA
18.3.15. Miltenyi Biotec GmbH
18.3.16. Novartis AG
18.3.17. Oxford Biomedica PLC
18.3.18. Sanofi SA
18.3.19. Sirion-Biotech GmbH
18.3.20. Spark Therapeutics, Inc. by F. Hoffmann-La Roche Ltd.
18.3.21. Takara Bio Inc.
18.3.22. Thermo Fisher Scientific Inc.
18.3.23. uniQure N.V.
18.3.24. VGXI, Inc. by GeneOne Life Science
18.3.25. Waisman Biomanufacturing
18.3.26. Wuxi AppTec Co., Ltd.
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. VIRAL VECTOR MANUFACTURING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY VECTOR TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY VECTOR TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY WORKFLOW, 2024 VS 2030 (%)
FIGURE 8. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY WORKFLOW, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DELIVERY METHOD, 2024 VS 2030 (%)
FIGURE 10. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DELIVERY METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE INDICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 18. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. VIRAL VECTOR MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. VIRAL VECTOR MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. VIRAL VECTOR MANUFACTURING MARKET: RESEARCHAI
FIGURE 30. VIRAL VECTOR MANUFACTURING MARKET: RESEARCHSTATISTICS
FIGURE 31. VIRAL VECTOR MANUFACTURING MARKET: RESEARCHCONTACTS
FIGURE 32. VIRAL VECTOR MANUFACTURING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. VIRAL VECTOR MANUFACTURING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY VECTOR TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY VECTOR TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ADENOVIRAL VECTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ADENOVIRAL VECTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY BACULOVIRAL VECTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY BACULOVIRAL VECTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY HERPES SIMPLEX VECTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY HERPES SIMPLEX VECTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY LENTIVIRAL VECTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY LENTIVIRAL VECTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PLASMID DNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PLASMID DNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY RETROVIRUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY RETROVIRUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY FORMULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY FORMULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PURIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PURIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY BIOREACTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY BIOREACTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY CELL CULTURE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY CELL CULTURE SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY MEDIA FORMULATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY MEDIA FORMULATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY EX VIVO, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY EX VIVO, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY CELL RE-INFUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY CELL RE-INFUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY CELL TRANSDUCTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY CELL TRANSDUCTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY EX VIVO, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY EX VIVO, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY IN VIVO, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY IN VIVO, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DIRECT INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DIRECT INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY INTRAVENOUS ROUTE, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY INTRAVENOUS ROUTE, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ORAL ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ORAL ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY IN VIVO, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY IN VIVO, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PURIFICATION TECHNIQUES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PURIFICATION TECHNIQUES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ULTRAFILTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ULTRAFILTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PURIFICATION TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PURIFICATION TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TRANSFECTION METHODS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TRANSFECTION METHODS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY CHEMICAL-BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY CHEMICAL-BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ELECTROPORATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ELECTROPORATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TRANSFECTION METHODS, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TRANSFECTION METHODS, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY GENE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY INHERITED DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY INHERITED DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ONCOLOGICAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ONCOLOGICAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY SINGLE GENE MUTATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY SINGLE GENE MUTATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ONCOLOGY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ONCOLOGY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY GENE INACTIVATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY GENE INACTIVATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ONCOLYTIC VIROTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ONCOLYTIC VIROTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TUMOR SUPPRESSOR GENES, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TUMOR SUPPRESSOR GENES, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ONCOLOGY RESEARCH, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ONCOLOGY RESEARCH, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY VACCINOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY VACCINOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY CANCER VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY CANCER VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ZOONOTIC DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ZOONOTIC DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY VACCINOLOGY, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY VACCINOLOGY, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY LARGE ENTERPRISES, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY LARGE ENTERPRISES, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY START-UPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY START-UPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 143. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ACADEMIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 144. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ACADEMIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 145. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY GOVERNMENT LABS, BY REGION, 2018-2024 (USD MILLION)
TABLE 146. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY GOVERNMENT LABS, BY REGION, 2025-2030 (USD MILLION)
TABLE 147. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2024 (USD MILLION)
TABLE 148. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY VECTOR TYPE, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY VECTOR TYPE, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY EX VIVO, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY EX VIVO, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY IN VIVO, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY IN VIVO, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PURIFICATION TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PURIFICATION TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TRANSFECTION METHODS, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TRANSFECTION METHODS, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 173. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 174. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 175. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ONCOLOGY RESEARCH, 2018-2024 (USD MILLION)
TABLE 176. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ONCOLOGY RESEARCH, 2025-2030 (USD MILLION)
TABLE 177. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY VACCINOLOGY, 2018-2024 (USD MILLION)
TABLE 178. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY VACCINOLOGY, 2025-2030 (USD MILLION)
TABLE 179. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 182. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 183. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 184. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 185. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2024 (USD MILLION)
TABLE 186. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2025-2030 (USD MILLION)
TABLE 187. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 188. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY VECTOR TYPE, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY VECTOR TYPE, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY EX VIVO, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY EX VIVO, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY IN VIVO, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY IN VIVO, 2025-2030 (USD MILLION)
TABLE 203. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 204. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 205. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PURIFICATION TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 206. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PURIFICATION TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 207. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TRANSFECTION METHODS, 2018-2024 (USD MILLION)
TABLE 208. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TRANSFECTION METHODS, 2025-2030 (USD MILLION)
TABLE 209. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 210. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 211. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 212. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 213. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 214. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 215. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ONCOLOGY RESEARCH, 2018-2024 (USD MILLION)
TABLE 216. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ONCOLOGY RESEARCH, 2025-2030 (USD MILLION)
TABLE 217. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY VACCINOLOGY, 2018-2024 (USD MILLION)
TABLE 218. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY VACCINOLOGY, 2025-2030 (USD MILLION)
TABLE 219. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 222. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 223. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 224. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 225. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2024 (USD MILLION)
TABLE 226. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2025-2030 (USD MILLION)
TABLE 227. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 228. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 229. CANADA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY VECTOR TYPE, 2018-2024 (USD MILLION)
TABLE 230. CANADA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY VECTOR TYPE, 2025-2030 (USD MILLION)
TABLE 231. CANADA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
TABLE 232. CANADA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
TABLE 233. CANADA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2024 (USD MILLION)
TABLE 234. CANADA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2025-2030 (USD MILLION)
TABLE 235. CANADA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2024 (USD MILLION)
TABLE 236. CANADA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2025-2030 (USD MILLION)
TABLE 237. CANADA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 238. CANADA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 239. CANADA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY EX VIVO, 2018-2024 (USD MILLION)
TABLE 240. CANADA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY EX VIVO, 2025-2030 (USD MILLION)
TABLE 241. CANADA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY IN VIVO, 2018-2024 (USD MILLION)
TABLE 242. CANADA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY IN VIVO, 2025-2030 (USD MILLION)
TABLE 243. CANADA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 244. CANADA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 245. CANADA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PURIFICATION TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 246. CANADA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PURIFICATION TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 247. CANADA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TRANSFECTION METHODS, 2018-2024 (USD MILLION)
TABLE 248. CANADA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TRANSFECTION METHODS, 2025-2030 (USD MILLION)
TABLE 249. CANADA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 250. CANADA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 251. CANADA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 252. CANADA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 253. CANADA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 254. CANADA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 255. CANADA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ONCOLOGY RESEARCH, 2018-2024 (USD MILLION)
TABLE 256. CANADA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ONCOLOGY RESEARCH, 2025-2030 (USD MILLION)
TABLE 257. CANADA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY VACCINOLOGY, 2018-2024 (USD MILLION)
TABLE 258. CANADA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY VACCINOLOGY, 2025-2030 (USD MILLION)
TABLE 259. CANADA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. CANADA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. CANADA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 262. CANADA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 263. CANADA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 264. CANADA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 265. CANADA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2024 (USD MILLION)
TABLE 266. CANADA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2025-2030 (USD MILLION)
TABLE 267. MEXICO VIRAL VECTOR MANUFACTURING MARKET SIZE, BY VECTOR TYPE, 2018-2024 (USD MILLION)
TABLE 268. MEXICO VIRAL VECTOR MANUFACTURING MARKET SIZE, BY VECTOR TYPE, 2025-2030 (USD MILLION)
TABLE 269. MEXICO VIRAL VECTOR MANUFACTURING MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
TABLE 270. MEXICO VIRAL VECTOR MANUFACTURING MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
TABLE 271. MEXICO VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2024 (USD MILLION)
TABLE 272. MEXICO VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2025-2030 (USD MILLION)
TABLE 273. MEXICO VIRAL VECTOR MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2024 (USD MILLION)
TABLE 274. MEXICO VIRAL VECTOR MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2025-2030 (USD MILLION)
TABLE 275. MEXICO VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 276. MEXICO VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 277. MEXICO VIRAL VECTOR MANUFACTURING MARKET SIZE, BY EX VIVO, 2018-2024 (USD MILLION)
TABLE 278. MEXICO VIRAL VECTOR MANUFACTURING MARKET SIZE, BY EX VIVO, 2025-2030 (USD MILLION)
TABLE 279. MEXICO VIRAL VECTOR MANUFACTURING MARKET SIZE, BY IN VIVO, 2018-2024 (USD MILLION)
TABLE 280. MEXICO VIRAL VECTOR MANUFACTURING MARKET SIZE, BY IN VIVO, 2025-2030 (USD MILLION)
TABLE 281. MEXICO VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 282. MEXICO VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 283. MEXICO VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PURIFICATION TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 284. MEXICO VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PURIFICATION TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 285. MEXICO VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TRANSFECTION METHODS, 2018-2024 (USD MILLION)
TABLE 286. MEXICO VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TRANSFECTION METHODS, 2025-2030 (USD MILLION)
TABLE 287. MEXICO VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 288. MEXICO VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 289. MEXICO VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 290. MEXICO VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 291. MEXICO VIRAL VECTOR MANUFACTURING MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 292. MEXICO VIRAL VECTOR MANUFACTURING MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 293. MEXICO VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ONCOLOGY RESEARCH, 2018-2024 (USD MILLION)
TABLE 294. MEXICO VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ONCOLOGY RESEARCH, 2025-2030 (USD MILLION)
TABLE 295. MEXICO VIRAL VECTOR MANUFACTURING MARKET SIZE, BY VACCINOLOGY, 2018-2024 (USD MILLION)
TABLE 296. MEXICO VIRAL VECTOR MANUFACTURING MARKET SIZE, BY VACCINOLOGY, 2025-2030 (USD MILLION)
TABLE 297. MEXICO VIRAL VECTOR MANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 298. MEXICO VIRAL VECTOR MANUFACTURING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 299. MEXICO VIRAL VECTOR MANUFACTURING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 300. MEXICO VIRAL VECTOR MANUFACTURING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 301. MEXICO VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 302. MEXICO VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 303. MEXICO VIRAL VECTOR MANUFACTURING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2024 (USD MILLION)
TABLE 304. MEXICO VIRAL VECTOR MANUFACTURING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2025-2030 (USD MILLION)
TABLE 305. BRAZIL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY VECTOR TYPE, 2018-2024 (USD MILLION)
TABLE 306. BRAZIL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY VECTOR TYPE, 2025-2030 (USD MILLION)
TABLE 307. BRAZIL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
TABLE 308. BRAZIL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY WORKF

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Viral Vector Manufacturing market report include:
  • ABL Inc.
  • Batavia Biosciences B.V. by CJ Cheiljedang
  • Biovian Oy
  • Charles River Laboratories International, Inc.
  • Creative Biogene
  • Danaher Corporation
  • FinVector Oy
  • FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
  • GE HealthCare Technologies, Inc.
  • Genezen Laboratories, Inc.
  • Kaneka Eurogentec S.A.
  • Lonza Group Ltd.
  • MaxCyte, Inc.
  • Merck KGaA
  • Miltenyi Biotec GmbH
  • Novartis AG
  • Oxford Biomedica PLC
  • Sanofi SA
  • Sirion-Biotech GmbH
  • Spark Therapeutics, Inc. by F. Hoffmann-La Roche Ltd.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • uniQure N.V.
  • VGXI, Inc. by GeneOne Life Science
  • Waisman Biomanufacturing
  • Wuxi AppTec Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages181
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 11 Billion
Forecasted Market Value ( USD ) by 2030 $ 27.5 Billion
Compound Annual Growth Rate20.0%
Regions CoveredGlobal
No. of Companies Mentioned27

Related Topics

Related Reports

Viral Vectors Market by Vector Type (Adeno Associated Virus, Adenovirus, Lentivirus), Application (Cell Therapy, Gene Therapy, Research), Therapeutic Area, End User, Production Stage, Production Scale - Global Forecast 2025-2030 - Product Image

Viral Vectors Market by Vector Type (Adeno Associated Virus, Adenovirus, Lentivirus), Application (Cell Therapy, Gene Therapy, Research), Therapeutic Area, End User, Production Stage, Production Scale - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Gene Delivery Technologies Market by Delivery Vector Type (Non-Viral Vector, Viral Vector), Therapeutic Application (Cardiovascular Therapies, Genetic Disorders, Oncology), Product, End User, Technology - Global Forecast 2025-2030 - Product Image

Gene Delivery Technologies Market by Delivery Vector Type (Non-Viral Vector, Viral Vector), Therapeutic Application (Cardiovascular Therapies, Genetic Disorders, Oncology), Product, End User, Technology - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Viral Vector Manufacturing Market Size, Share, Trends and Forecast by Type, Disease, Application, End User, and Region, 2025-2033 - Product Image

Viral Vector Manufacturing Market Size, Share, Trends and Forecast by Type, Disease, Application, End User, and Region, 2025-2033

  • Report
  • 146 Pages
  • Global
From
Viral Vector Manufacturing, Non-Viral Vector Manufacturing and Gene Therapy Manufacturing Market Industry Trends and Global Forecasts to 2035, by Scale of Operation, Type of Vector, Application Area, Therapeutic Area, Type of Manufacturer and Geographical Region - Product Image

Viral Vector Manufacturing, Non-Viral Vector Manufacturing and Gene Therapy Manufacturing Market Industry Trends and Global Forecasts to 2035, by Scale of Operation, Type of Vector, Application Area, Therapeutic Area, Type of Manufacturer and Geographical Region

  • Report
  • 768 Pages
  • Global
From
Viral Vector Vaccines Market Report and Forecast 2025-2034 - Product Image

Viral Vector Vaccines Market Report and Forecast 2025-2034

  • Report
  • 350 Pages
  • Global
From

About the Viral Vector Manufacturing Market

The Viral Vector Manufacturing market is a subset of the genomics industry that focuses on the production of viral vectors for gene therapy. Viral vectors are modified viruses that are used to deliver genetic material into cells, allowing for the expression of a desired gene. This technology has been used to treat a variety of diseases, including cancer, cystic fibrosis, and hemophilia. The Viral Vector Manufacturing market is highly competitive, with a number of companies offering a range of services. These services include vector design, vector production, and vector characterization. Companies also provide custom services to meet the specific needs of their customers. Some of the major players in the Viral Vector Manufacturing market include Lonza, Thermo Fisher Scientific, Merck KGaA, and Oxford BioMedica. These companies offer a range of services, from vector design to vector production and characterization. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.